adrenergic agents

Preferred Label : adrenergic agents;

MeSH definition : Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.;

MeSH synonym : agents, adrenergic; adrenergic drugs; drugs, adrenergic; adrenergics; Adrenergic Drug; Drug, Adrenergic; Adrenergic; Adrenergic Agent; Agent, Adrenergic;

MeSH hyponym : adrenergic neurohumor depleters; sympathetic transmitter releasers; adrenergic release inhibitors; adrenergic synthesis inhibitors; adrenergic neuron agents; Inhibitors, Adrenergic Release; Release Inhibitors, Adrenergic; Inhibitors, Adrenergic Synthesis; Synthesis Inhibitors, Adrenergic; Depleters, Adrenergic Neurohumor; Neurohumor Depleters, Adrenergic; Agents, Adrenergic Neuron; Neuron Agents, Adrenergic; Adrenergic Neuron Drugs; Drugs, Adrenergic Neuron; Neuron Drugs, Adrenergic; Releasers, Sympathetic Transmitter; Transmitter Releasers, Sympathetic;

Related MeSH term : adrenergic effect; Effect, Adrenergic; Adrenergic Effects; Effects, Adrenergic;

MeSH annotation : note entry term ADRENERGIC EFFECT: use only for the adrenergic effect of a chemical substance;

Wikipedia link : https://en.wikipedia.org/wiki/Adrenergic agents;

Is substance : O;

action pharmacologique : O;

Détails

Origin ID

D018663;

UMLS CUI

C0001637;

ATC code(s)
- adrenergics and other drugs for obstructive airway diseases [ATC Code]
- adrenergics for systemic use [ATC Code]
- adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics [ATC Code]
- adrenergics, inhalants [ATC Code]
- antiadrenergic agents, ganglion-blocking [ATC Code]
- combinations of rauwolfia alkoloids, combinations [ATC Code]
- guanidine derivatives [ATC Code]
- rauwolfia alkaloids [ATC Code]
- theophylline and adrenergics [ATC Code]
- xanthines and adrenergics [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Adrenal ENT agent [ICD-11 Extension code]
- Product containing sympathomimetic (product) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Adrenergic Agent [NCIt concept]
Record concept(s)
- adrenergic agents [MeSH concept]
- adrenergic effect [MeSH concept]
- adrenergic neurohumor depleters [MeSH concept]
- adrenergic neuron agents [MeSH concept]
- adrenergic release inhibitors [MeSH concept]
- adrenergic synthesis inhibitors [MeSH concept]
- sympathetic transmitter releasers [MeSH concept]
See also
- sympatholytics [MeSH Descriptor]
- sympathomimetics [MeSH Descriptor]
See also inter- (CISMeF)
- sympathomimetic agent, nos [SNOMED Notion]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- Brimonidine Tartrate [MeSH Descriptor]
- DSP 4 [MeSH Supplementary Concept]
- Formoterol Fumarate [MeSH Descriptor]
- Nebivolol [MeSH Descriptor]
- Rilmenidine [MeSH Descriptor]
- Salmeterol Xinafoate [MeSH Descriptor]
- albuterol [MeSH Descriptor]
- bethanidine [MeSH Descriptor]
- clenbuterol [MeSH Descriptor]
- clonidine [MeSH Descriptor]
- debrisoquin [MeSH Descriptor]
- dexmedetomidine [MeSH Descriptor]
- dobutamine [MeSH Descriptor]
- ephedrine [MeSH Descriptor]
- epinephrine [MeSH Descriptor]
- ergotamine [MeSH Descriptor]
- etilefrine [MeSH Descriptor]
- fenoterol [MeSH Descriptor]
- guanabenz [MeSH Descriptor]
- guanethidine [MeSH Descriptor]
- guanfacine [MeSH Descriptor]
- hexoprenaline [MeSH Descriptor]
- isoetharine [MeSH Descriptor]
- isoproterenol [MeSH Descriptor]
- isoxsuprine [MeSH Descriptor]
- medetomidine [MeSH Descriptor]
- mephentermine [MeSH Descriptor]
- metaproterenol [MeSH Descriptor]
- metaraminol [MeSH Descriptor]
- methoxamine [MeSH Descriptor]
- methyldopa [MeSH Descriptor]
- midodrine [MeSH Descriptor]
- naphazoline [MeSH Descriptor]
- norepinephrine [MeSH Descriptor]
- nylidrin [MeSH Descriptor]
- octopamine [MeSH Descriptor]
- oxidopamine [MeSH Descriptor]
- oxyfedrine [MeSH Descriptor]
- oxymetazoline [MeSH Descriptor]
- phentermine [MeSH Descriptor]
- phenylephrine [MeSH Descriptor]
- phenylpropanolamine [MeSH Descriptor]
- prenalterol [MeSH Descriptor]
- prenylamine [MeSH Descriptor]
- procaterol [MeSH Descriptor]
- racepinephrine [MeSH Descriptor]
- ritodrine [MeSH Descriptor]
- synephrine [MeSH Descriptor]
- terbutaline [MeSH Descriptor]
- tetrahydropalmatine [MeSH Supplementary Concept]
- tretoquinol [MeSH Descriptor]
- xamoterol [MeSH Descriptor]
- xylazine [MeSH Descriptor]
UMLS correspondences (same concept)
- Adrenergic Agent [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients